Condition

Liver Neoplasms clinical trials and research

• 17Clinical trials
• 2NIH research projects
• 17Countries

Newest Liver Neoplasms clinical trials

All recruiting trials (17)

• Multimodal Survival Predictor for Colorectal Liver Metastases After Surgery

  Researchers are testing a tool that combines MRI-derived tumor features with clinical data to predict survival after surgery for colorectal liver metastases.

  Recruiting Anhui Provincial Hospital · Hefei, Anhui · NCT07830576

• Predicting liver failure after major liver surgery using CT measurements and vascular shape changes

  Doctors are testing whether adding vascular deformation mapping to CT measurements can better predict liver failure after removing a large portion of the liver.

  Recruiting at 3 sites Minia University · Minya, Minya Governorate and 2 other locations · NCT07727759

• Camera-based non-contact vital sign monitoring during surgery

  This project will try a camera-based non-contact system to measure heart rate, blood pressure, and oxygen levels in adults having surgery under general anesthesia.

  Recruiting Taipei Veterans General Hospital, Taiwan · Taipei · NCT07473687

• Blood biomarker changes before and after TACE for hepatocellular carcinoma

  This will see if blood biomarkers change after TACE and whether those changes match early CT/MRI response in adults with hepatocellular carcinoma.

  Recruiting University of Belgrade · Belgrade · NCT07378709

• TheraSphere Y-90 glass microsphere treatment for liver tumors in Japan

  This will test whether TheraSphere Y-90 glass microspheres are safe and helpful for Japanese adults with primary or secondary liver cancer who are not candidates for standard treatments.

  Recruiting at 5 sites Boston Scientific Corporation · Nishinomiya, Hyōgo and 4 other locations · NCT07377487

• Carbon ion radiotherapy plus atezolizumab and bevacizumab for advanced hepatocellular carcinoma

  This trial will try adding carbon ion radiotherapy to standard atezolizumab‑bevacizumab treatment for adults with advanced hepatocellular carcinoma to see if it controls tumors better and improves survival.

  Recruiting Phase 2 Yonsei University · Seoul · NCT07246668

• PF-08634404 alone or with ipilimumab for adults with advanced hepatocellular carcinoma not removable by surgery

  This tests PF-08634404 by itself and together with ipilimumab in adults whose hepatocellular carcinoma is advanced and cannot be removed surgically.

  Recruiting at 60 sites Phase 1/2 Pfizer · Irvine, California and 59 other locations · NCT07227012

• Contrast-Enhanced Super-Resolution (CESR) Ultrasound for Imaging Breast, Liver, and Kidney Lesions

  The team will try a new contrast-enhanced super-resolution ultrasound (CESR) to see if it images known lesions in the breast, liver, or kidney more clearly in adults scheduled for biopsy and in healthy volunteers.

  Recruiting Phase 2 UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT07225114

• Multimodal ablation with Tislelizumab, lenvatinib and TACE for unresectable primary liver cancer

  This trial will test whether combining multimodal ablation with Tislelizumab (a PD‑1 antibody), lenvatinib, and TACE helps people with unresectable primary liver cancer.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT06794073

• Evaluating AST-201 for GPC3-positive advanced solid tumors

  This study is testing a new treatment called AST-201 to see if it can help people with advanced solid tumors that have a specific marker called GPC3.

  Recruiting at 4 sites Phase 1 Aptamer Sciences, Inc. · Goyang-si, Gyeonggi-do and 3 other locations · NCT06687941

• Treatment for breast cancer that has spread to the liver using a new ablation technique

  This study is testing a new treatment method for breast cancer that has spread to the liver to see if it works better than the standard approach.

  Recruiting Ruijin Hospital · Shanghai · NCT06567353

• Evaluation of the HistoSonics Edison System for treating liver tumors

  This study is testing how well the HistoSonics Edison System works for treating liver tumors and how different factors affect the treatment's success in real patients.

  Recruiting at 32 sites HistoSonics, Inc. · Mobile, Alabama and 34 other locations · NCT06486454

• Using ultrasound to assess liver tumor treatment response

  This study is testing if using a special ultrasound during liver cancer treatment can help doctors see how well the treatment is working sooner than traditional imaging methods.

  Recruiting Phase 2 Thomas Jefferson University · Philadelphia, Pennsylvania · NCT06261814

• Comparing methods to increase liver size before surgery

  This study is testing three different ways to help increase liver size before surgery for patients with liver tumors to see which method works best.

  Recruiting Medical University of Warsaw · Warsaw, Masovian Voivodeship · NCT06050200

• ET140203 T Cells for treating pediatric liver cancer

  This study is testing a new type of T-cell treatment for kids with certain types of liver cancer to see if it is safe and helps them feel better.

  Recruiting at 4 sites Phase 1/2 Eureka Therapeutics Inc. · Los Angeles, California and 3 other locations · NCT04634357

• Evaluating the impact of MR-guided radiation therapy on cancer treatment outcomes

  This study is testing how using a special type of radiation therapy with real-time imaging can improve treatment results and quality of life for adults with cancer.

  Recruiting at 14 sites UMC Utrecht · Pittsburgh, Pennsylvania and 17 other locations · NCT04075305

• Comparing spinal and epidural anesthesia for liver surgery recovery

  This study is testing whether spinal anesthesia can help people recovering from liver surgery feel better and recover faster compared to epidural anesthesia.

  Recruiting University of Manitoba · Winnipeg, Manitoba · NCT03715517

NIH-funded research (2)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Tests to predict risk in children with liver tumors

  This project is creating lab tests to help doctors tell which children with liver tumors need stronger treatment and which can avoid it.

  NIH research Baylor College of Medicine · Houston, United States · NIH-11124124

• Identifying risk levels in children with liver tumors

  This study is looking to help kids with liver tumors by figuring out their individual risk levels, so doctors can give them the best treatment possible—some may need stronger therapies, while others can skip the harsh side effects of high-dose chemotherapy.

  NIH research Baylor College of Medicine · Houston, United States · NIH-10868737

Related topics

Quick answers

How many Liver Neoplasms clinical trials are recruiting right now?

17, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 17 countries. The most sites are in United States (6 trials), China (4 trials), Taiwan (2 trials), South Korea (2 trials), Canada (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1/2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →